SI
IART icon

Sapience Investments’s Integra LifeSciences IART Stock Holding History

Sapience Investments’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18K Sell
1,914
-45,468
-96% -$499K 2.34% 7
2025
Q4 		$588K Buy
47,382
+7,385
+18% +$98.2K 2.22% 21
2025
Q3 		$573K Sell
39,997
-178,995
-82% -$2.45M 2.25% 16
2025
Q2 		$2.69M Buy
218,992
+76,170
+53% +$1.11M 1.79% 16
2025
Q1 		$3.14M Sell
142,822
-21,953
-13% -$516K 2.24% 3
2024
Q4 		$3.74M Buy
164,775
+24,830
+18% +$542K 2.18% 6
2024
Q3 		$2.54M Sell
139,945
-260
-0.2% -$6.03K 1.26% 37
2024
Q2 		$4.09M Sell
140,205
-15,592
-10% -$462K 2.09% 6
2024
Q1 		$5.52M Sell
155,797
-75,340
-33% -$3.01M 1.83% 15
2023
Q4 		$10.1M Sell
231,137
-14,563
-6% -$573K 2.4% 6
2023
Q3 		$9.38M Buy
245,700
+21,481
+10% +$904K 2.26% 12
2023
Q2 		$9.22M Buy
224,219
+31,650
+16% +$1.52M 2.07% 13
2023
Q1 		$11.1M Sell
192,569
-11,280
-6% -$636K 2.56% 8
2022
Q4 		$11.4M Sell
203,849
-53,250
-21% -$2.71M 2.4% 7
2022
Q3 		$10.9M Buy
257,099
+92,010
+56% +$4.71M 2.29% 6
2022
Q2 		$8.92M Sell
165,089
-32,351
-16% -$1.94M 1.67% 23
2022
Q1 		$12.7M Sell
197,440
-7,950
-4% -$523K 1.54% 25
2021
Q4 		$13.8M Buy
205,390
+27,785
+16% +$1.88M 1.57% 29
2021
Q3 		$12.2M Buy
177,605
+15,945
+10% +$1.13M 1.44% 35
2021
Q2 		$11M Sell
161,660
-7,665
-5% -$542K 1.37% 34
2021
Q1 		$11.7M Sell
169,325
-79,310
-32% -$5.37M 1.47% 32
2020
Q4 		$16.1M Sell
248,635
-18,280
-7% -$984K 2.24% 7
2020
Q3 		$12.6M Buy
266,915
+54,210
+25% +$2.58M 2.24% 5
2020
Q2 		$9.99M Sell
212,705
-60,355
-22% -$2.97M 1.84% 13
2020
Q1 		$12.2M Buy
273,060
+18,830
+7% +$988K 2.71% 1
2019
Q4 		$14.8M Buy
254,230
+90,720
+55% +$5.4M 2.07% 12
2019
Q3 		$9.82M Sell
163,510
-300
-0.2% -$17.9K 1.37% 27
2019
Q2 		$9.15M Buy
163,810
+31,000
+23% +$1.6M 1.25% 30
2019
Q1 		$7.4M Buy
+132,810
New +$6.76M 0.98% 43
2017
Q1 		– Sell
-70,400
Closed -$3.02M – 86
2016
Q4 		$3.02M Buy
+70,400
New +$2.86M 0.93% 61

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sapience Investments's IART Position: Q1 2026 in Review

Sapience Investments reduced its Integra LifeSciences (IART) stake by 96% in Q1 2026, selling an estimated $499K and leaving 1,914 shares worth $18K. The position accounts for 2.34% of the portfolio, ranked #7.

Sapience Investments first reported a position in IART in Q4 2016 and has held it in 30 quarters since. The position peaked at $16.1M in Q4 2020. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Sapience Investments held 1,914 shares of Integra LifeSciences worth $18K as of Q1 2026.
  • Sapience Investments sold 45,468 Integra LifeSciences shares in Q1 2026, an estimated $499K.
  • Integra LifeSciences made up 2.34% of Sapience Investments's portfolio in Q1 2026, its #7 holding.
  • Sapience Investments first reported a position in Integra LifeSciences in Q4 2016 and has held it in 30 quarters since.
  • Sapience Investments's Integra LifeSciences position peaked at $16.1M in Q4 2020.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Sapience Investments's 13F filing for Q1 2026, filed 15 May 2026.